Published in Clin Nephrol on January 01, 1987
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood (1995) 16.81
Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) (1996) 4.52
Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med (1996) 3.61
Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS (1996) 2.28
A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat (2006) 2.00
Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Rheumatology (Oxford) (2008) 1.71
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology (1994) 1.69
Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol (2000) 1.61
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum (1997) 1.55
Video-thoracoscopic pericardial window in the diagnosis and treatment of pericardial effusions. Am J Cardiol (1998) 1.55
Idiopathic acute interstitial nephritis associated with anterior uveitis in adults. Clin Nephrol (1989) 1.53
Mortality in Behçet's disease. Arthritis Rheum (2010) 1.53
Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum (2000) 1.52
Peripheral arterial disease and isolated systolic hypertension: the ATTEST study. J Hum Hypertens (2008) 1.49
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47
Chloroquine-quinacrine association in resistant cutaneous lupus. Dermatology (1995) 1.46
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut (1999) 1.44
REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis (2008) 1.42
Renal tolerance for ioxaglate in patients with chronic renal failure. Radiology (1991) 1.42
[Pharmacokinetic changes in renal failure]. Presse Med (2001) 1.41
Machine perfusion in clinical trials: the preservation solution bias. Transpl Int (2011) 1.40
Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) (1999) 1.39
The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. Hum Exp Toxicol (2012) 1.39
Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis. Clin Exp Rheumatol (1996) 1.39
Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat (2007) 1.39
[Liver disease and pregnancy]. Rev Med Interne (2008) 1.39
Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care (2003) 1.38
[Severe form of hemorrhagic fever with renal syndrome. An autochtonous case observed in Parisian suburbs]. Presse Med (1991) 1.37
Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol (1989) 1.35
Neurological complications of primary Sjögren's syndrome. J Neurol (2001) 1.34
Fatigue in patients with chronic hepatitis C. J Viral Hepat (2002) 1.30
Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) (2010) 1.25
Characterization of cryoglobulins by immunoblotting. Clin Chem (1992) 1.24
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium. Biomed Pharmacother (1994) 1.23
Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol (2010) 1.22
Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol (1997) 1.20
Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. Arthritis Rheum (2012) 1.19
Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant (2001) 1.17
Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population. Diabetes Obes Metab (2007) 1.16
[Vitamin D and autoimmunity. First part: Fundamental aspects]. Rev Med Interne (2011) 1.12
Assessing residents' prescribing behavior in renal impairment. Int J Qual Health Care (2003) 1.10
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev (2011) 1.10
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol (2000) 1.09
Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N Engl J Med (1987) 1.08
[Vitamin D and autoimmunity. Second part: Clinical aspects]. Rev Med Interne (2011) 1.07
Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status. J Viral Hepat (2006) 1.06
Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol (2000) 1.05
Nephrotoxicity of cyclosporin A in bone-marrow transplantation. Lancet (1981) 1.05
Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) (2006) 1.05
Molecular analysis of clonality in Castleman's disease. Blood (1995) 1.04
Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis (2001) 1.04
Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology (2000) 1.04
Cancer and renal insufficiency results of the BIRMA study. Br J Cancer (2010) 1.03
Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thromb Haemost (1999) 1.02
Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Ann Rheum Dis (2008) 1.02
Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol (1995) 1.01
MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. J Immunol (2001) 1.01
Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum (2009) 1.01
Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse. J Clin Microbiol (2001) 1.01
Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab (2006) 1.00
Chronic intestinal pseudo-obstruction in systemic lupus erythematosus. Gut (1998) 0.99
Pharmacokinetic of nevirapine in haemodialysis. Nephrol Dial Transplant (2001) 0.98
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol (2010) 0.98
[Castleman's disease]. Rev Med Interne (1996) 0.98
Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol (2015) 0.98
Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosa. Protein Sci (1994) 0.98
Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol (2005) 0.97
Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol (1999) 0.97
Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol (2001) 0.97
Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation. Arthritis Rheum (2013) 0.97
Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature. Clin Neuropathol (2009) 0.96
AL cardiac amyloidosis and arterial thromboembolic events. Scand J Rheumatol (2005) 0.96
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol (2000) 0.96
The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders. Ann Rheum Dis (2008) 0.96
Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Ann Rheum Dis (2008) 0.96
Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure. Magn Reson Imaging (1992) 0.95
Baclofen neurotoxicity [correction of unerotoxicity] in a chronic haemodialysis patient. Nephrol Dial Transplant (2000) 0.95
How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl (2006) 0.95
[Hydatid cyst of the pancreas]. J Chir (Paris) (2005) 0.95
Postvaccine vasculitis: a report of three cases. Rev Med Interne (2001) 0.95
Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Arthritis Rheum (2000) 0.95
Endothelin-1 in pulmonary hypertension. N Engl J Med (1993) 0.95
HHV-8 and multiple myeloma in France. Lancet (1997) 0.94
Slow viral dynamics of hepatitis C virus genotype 4. J Viral Hepat (2003) 0.93
[Etiologic factors in primary bronchial carcinoma in Tunisia]. Tunis Med (1993) 0.93
[Antiphospholipid antibodies, antiphospholipid syndrome and viral infections]. Rev Med Interne (2008) 0.93
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome. Ann Rheum Dis (2008) 0.92
[Acute renal failure during indomethacin treatment. 6 cases (author's transl)]. Nouv Presse Med (1980) 0.91
Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases. Clin Nephrol (1990) 0.91
The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65. Eur J Immunol (2001) 0.91
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res (1998) 0.91
Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides. Ann Rheum Dis (2008) 0.91
Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. Lupus (2008) 0.90
Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Immunol Lett (1998) 0.90
Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients. Aliment Pharmacol Ther (2009) 0.90
Long-term renal effect of cisplatin in man. Am J Nephrol (1994) 0.90